This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Explore conversion timing for a two-earner couple, including tax impact, income thresholds, and optimal years to convert for long-term growth.
18,272 articlesHims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Ibotta's Q1 2026 earnings reveal a company balancing rapid user growth with a longer road to sustainable profitabilit...
Discover what the AENT 2026 earnings transcript reveals about growth, margins, and cash flow. This guide translates t...
ON Semiconductor climbs to fresh highs in 2026 as AI data-center demand and GaN power tech power a strong cash flow-l...
Could Palantir move higher over the next year? This guide breaks down three realistic scenarios, key catalysts, and p...
Nebius Group stunned investors with a strong May, signaling momentum in its AI cloud push. This guide breaks down wha...
Broadcom stock is bouncing higher as the company rides a wave of AI and data-center demand. This in-depth guide break...
Micron Technology stunned investors by guiding for a $50 billion fourth-quarter revenue, underscoring data-center dem...
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
SpaceX finally faces the public market with its first earnings call after the IPO. This guide breaks down what invest...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...